Lupin granted approval for generic Lumigan

MUMBAI and BALTIMORE — Lupin received approval from the Food and Drug Administration for its bimatoprost ophthalmic solution, 0.03%, the generic version of Lumigan ophthalmic solution from Allergan. Lupin said its U.S. subsidiary would begin marketing the solution shortly. 

 

The drug is used to reduce elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension, according to the company.